Literature DB >> 7669589

Childhood T-cell lymphoblastic lymphoma--does early resolution of mediastinal mass predict for final outcome? The United Kingdom Children's Cancer Study Group (UKCCSG).

S F Shepherd1, R P A'Hern, C R Pinkerton.   

Abstract

This study presents a retrospective review of chest radiography in children with Murphy stage III T-cell lymphoblastic lymphoma. All received a standard leukaemia-based protocol with intensive induction, consolidation and continuing chemotherapy. Neither initial thoracic disease bulk nor the presence of a pleural effusion predicted outcome. However a significant difference was found when the 50 patients in whom the chest radiograph returned to normal within 60 days of commencing treatment were compared with the 18 patients with persistent mediastinal abnormalities, for both event-free [hazard ratio < or = 60 days to > 60 days (HR) 3.55 (95% CI 1.33-9.48); P = 0.007] and overall survival [HR 2.95 (95% CI 1.07-8.18); P = 0.03]. It appears that this relatively simple estimate of chemosensitivity may identify a group of particularly good-risk patients in whom drugs associated with late morbidity such as anthracyclines may be reduced and conversely a higher risk group in whom further intensification of treatment would be justified.

Entities:  

Mesh:

Year:  1995        PMID: 7669589      PMCID: PMC2033893          DOI: 10.1038/bjc.1995.405

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  10 in total

1.  Prognostic factors in childhood T-cell acute lymphoblastic leukemia: a Pediatric Oncology Group study.

Authors:  J J Shuster; J M Falletta; D J Pullen; W M Crist; G B Humphrey; B L Dowell; M D Wharam; M Borowitz
Journal:  Blood       Date:  1990-01-01       Impact factor: 22.113

2.  Regression of mediastinal Hodgkin disease after therapy: evaluation of time interval.

Authors:  L B North; L M Fuller; J A Sullivan-Halley; F B Hagemeister
Journal:  Radiology       Date:  1987-09       Impact factor: 11.105

3.  Clinical features and outcome in childhood T-cell leukemia-lymphoma according to stage of thymocyte differentiation: a Pediatric Oncology Group Study.

Authors:  W M Crist; J J Shuster; J Falletta; D J Pullen; C W Berard; T J Vietti; C S Alvarado; M A Roper; E Prasthofer; C E Grossi
Journal:  Blood       Date:  1988-12       Impact factor: 22.113

4.  Heterogeneity of presenting features and their relation to treatment outcome in 120 children with T-cell acute lymphoblastic leukemia.

Authors:  C H Pui; F G Behm; B Singh; M J Schell; D L Williams; G K Rivera; D K Kalwinsky; J T Sandlund; W M Crist; S C Raimondi
Journal:  Blood       Date:  1990-01-01       Impact factor: 22.113

Review 5.  Pediatric leukemia/lymphoma with t(8;14)(q24;q11).

Authors:  B J Lange; S C Raimondi; N Heerema; P C Nowell; J Minowada; P E Steinherz; E B Arenson; R O'Connor; D Santoli
Journal:  Leukemia       Date:  1992-07       Impact factor: 11.528

6.  Cytogenetic studies of 44 T-cell acute lymphoblastic leukemias.

Authors:  R Berger; M Le Coniat; D Vecchione; J Derré; S J Chen
Journal:  Cancer Genet Cytogenet       Date:  1990-01

7.  Effectiveness of a six-drug regimen (APO) without local irradiation for treatment of mediastinal lymphoblastic lymphoma in children.

Authors:  B M Camitta; S J Lauer; J T Casper; P A Kirchner; L E Kun; H W Oechler; S E Adair
Journal:  Cancer       Date:  1985-08-15       Impact factor: 6.860

8.  Long-term results of the APO protocol (vincristine, doxorubicin [adriamycin], and prednisone) for treatment of mediastinal lymphoblastic lymphoma.

Authors:  H J Weinstein; J R Cassady; R Levey
Journal:  J Clin Oncol       Date:  1983-09       Impact factor: 44.544

9.  Treatment of advanced stage T cell lymphoblastic lymphoma: results of the United Kingdom Children's Cancer Study Group (UKCCSG) protocol 8503.

Authors:  O B Eden; I Hann; J Imeson; S Cotterill; M Gerrard; C R Pinkerton
Journal:  Br J Haematol       Date:  1992-10       Impact factor: 6.998

10.  Adjuvant low dose radiation in childhood T cell leukaemia/lymphoma (report from the United Kingdom Childrens' Cancer Study Group--UKCCSG).

Authors:  M G Mott; J M Chessells; M L Willoughby; J R Mann; P H Morris-Jones; J S Malpas; M K Palmer
Journal:  Br J Cancer       Date:  1984-10       Impact factor: 7.640

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.